James Oliviero, Chief Financial Officer at Keryx Biopharma, holds 2.73M shares in Checkpoint Therapeutics (Ticker: CKPT), holds 209.41K shares in Keryx Biopharma (Ticker: KERX).

See the Hottest Stocks Based on Insider Trading >

James Oliviero
Keryx Biopharma (KERX)
Chief Financial Officer

Ranked #68,207 out of 78,624 Corporate Insiders

Profitable Transactions

17 out of 39 Profitable Transactions

Average Return

-9.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

CKPT

A breakdown of James Oliviero's holdings

See the Top Stocks by Insiders

Insider Roles

Checkpoint Therapeutics
(CKPT)

CEO, President and Director, Director

Roles that James Oliviero holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Keryx Biopharma
(KERX)

Rating:Informative Buy

Date:May 22, 2009 - May 22, 2010

Return:+692.80%

The most profitable trade made by James Oliviero

See the Latest Stocks Traded by Insiders

James Oliviero's Trading History

KERX

Keryx Biopharma

Jul 08, 2015

―

Informative Sell

18.67K

$703.60K

CKPT

Checkpoint Therapeutics

Feb 25, 2020

CEO, President and Director, Director

Uninformative Buy

―

$6.48M

List of latest transactions for each holding click on a transaction to see James Oliviero's performance on stock

See All Insider Trading from Today

James Oliviero insider profile FAQ

What is the percentage of profitable transactions made by James Oliviero?

The percentage of profitable transactions made by James Oliviero is 44%.

What is the average return per transaction made by James Oliviero?

The average return per transaction made by James Oliviero is -9.30%.

What stocks does James Oliviero hold?

James Oliviero holds: KERX, CKPT stocks.

What was James Oliviero’s latest transaction?

James Oliviero latest transaction was an Uninformative Buy of ―.

What was James Oliviero's most profitable transaction?

James Oliviero’s most profitable transaction was an Informative Buy of KERX stock on May 22, 2009. The return on the trade was 692.80%.

What is James Oliviero's role in Keryx Biopharma?

James Oliviero's role in Keryx Biopharma is Chief Financial Officer.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

James Oliviero Insider Profile

James Oliviero Keryx Biopharma (KERX)Chief Financial Officer